Literature DB >> 3221263

A feline model for experimental studies of peritumor brain edema.

J Bayens-Simmonds1, D P Boisvert, M E Castro, E S Johnson.   

Abstract

An in vivo model for correlative imaging studies of intracerebral glial tumors and peritumor brain edema has been developed. Adult male and female cats implanted with 1 x 10(6) or 5 x 10(5) 9L glioma cells had parietal tumors of 4 mm or greater in diameter and showed signs of increased intracranial pressure 13.7 +/- 1.9 days or 19.2 +/- 1.3 days after implantation. No immunosuppression was required and the success rate for tumor growth after implantation was 88%. Histologically, the tumor resembles a malignant astrocytoma. The tumor contained the highest water content (85.94%); peritumor white matter was more edematous (73.01%) than white matter in the contralateral hemisphere (69.04%), sham-operated (69.41%) and control brain (68.76%). There was no correlation between the size of the tumor and water content in tumor or white matter. Increased tissue albumin in peritumor white matter indicated blood-brain barrier dysfunction within the tumor and confirmed the vasogenic origin of the edema. Proton magnetic resonance imaging provided good spatial and contrast resolution with increased signal intensity in edematous white matter, decreasing with distance from the tumor. The large brain of this animal model allows the use of serial imaging and regional correlative biochemical measurements in a single animal. Other advantages of this model are its predictability and the short time required to produce tumors with marked peritumor edema.

Entities:  

Mesh:

Year:  1988        PMID: 3221263     DOI: 10.1007/bf00177435

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  21 in total

1.  IS THE BRAIN "AN IMMUNOLOGICALLY PRIVILEGED SITE"?I. STUDIES BASED ON INTRACEREBRAL TUMOR HOMOTRANSPLANTATION AND ISOTRANSPLANTATION TO SENSITIZED HOSTS.

Authors:  L C SCHEINBERG; F L EDELMAN; W A LEVY
Journal:  Arch Neurol       Date:  1964-09

2.  Chemotherapy of brain tumors.

Authors:  N A Vick; J D Khandekar; D D Bigner
Journal:  Arch Neurol       Date:  1977-09

3.  Brain tumors induced in adult monkeys by Schmidt-Ruppin strain of Rous sarcoma virus.

Authors:  T Kumanishi; F Ikuta; K Nishida; K Ueki; T Yamamoto
Journal:  Gan       Date:  1973-12

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Therapeutic potential for blood-brain barrier modification in malignant brain tumor.

Authors:  E A Neuwelt
Journal:  Prog Exp Tumor Res       Date:  1984

6.  Permeability characteristics of brain adjacent to tumors in rats.

Authors:  V A Levin; M Freeman-Dove; H D Landahl
Journal:  Arch Neurol       Date:  1975-12

7.  Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects.

Authors:  A Fontana; H Hengartner; N de Tribolet; E Weber
Journal:  J Immunol       Date:  1984-04       Impact factor: 5.422

8.  Experimental glioma in primates: a computed tomography model.

Authors:  K G Rieth; G Di Chiro; W T London; J L Sever; S A Houff; P L Kornblith; P E McKeever; C Buonomo; B L Padgett; D L Walker
Journal:  J Comput Assist Tomogr       Date:  1980-06       Impact factor: 1.826

9.  Perivascular lymphocytic cuffing in astrocytomas.

Authors:  J Takeuchi; R O Barnard
Journal:  Acta Neuropathol       Date:  1976       Impact factor: 17.088

10.  Computed tomography of virally induced canine brain tumors: a preliminary report.

Authors:  D R Groothuis; M A Mikhael; J M Fischer; J F Pasternak; T Fouts; D D Bigner; N A Vick
Journal:  J Comput Assist Tomogr       Date:  1981-08       Impact factor: 1.826

View more
  4 in total

1.  Morphometrical characterization of two glioma models in the brain of immunocompetent and immunodeficient rats.

Authors:  M Saini; M Bellinzona; F Meyer; G Cali; M Samii
Journal:  J Neurooncol       Date:  1999-03       Impact factor: 4.130

2.  Inhibition of angiogenesis and tumor growth in the brain. Suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor.

Authors:  S S Brem; D Zagzag; A M Tsanaclis; S Gately; M P Elkouby; S E Brien
Journal:  Am J Pathol       Date:  1990-11       Impact factor: 4.307

3.  Suramin inhibits glioma cell proliferation in vitro and in the brain.

Authors:  S Takano; S Gately; H Engelhard; A M Tsanaclis; S Brem
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

4.  Characterization of 9L glioma model of the Wistar rat.

Authors:  Maja Stojiljkovic; Vesna Piperski; Mirjana Dacevic; Ljubisav Rakic; Sabera Ruzdijic; Selma Kanazir
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.